The Latest Breaking News from MHRA

Small Pharma Inc. (OTCQB: DMTTF), a biotech company developing short-acting psychedelic-assisted therapies for diverse mental health disorders, reported its financial results for the three and six months ended August 31, 2022. For the period numbers show:

Every tobacco and e-cigarette outlet across the region has been written to in an unusual move.

In a study carried out by Nuffield Health Group, one in four women said they struggled to cope with life due to menopause symptoms. Hormone replacement therapy is a treatment used by those struggling with the debilitating symptoms, and now for the first time the medicine is available over the…

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a second Coronavirus booster vaccine to target the Omicron variant ahead of the autumn booster programme

It’s the second jab aimed at both the original and Omicron strains of the virus, to be approved in the UK

The "bivalent" jab - which targets Omicron as well as the original strain of the deadly virus - is manufactured by Pfizer/Biotech, and follows a similar booster from Moderna approved last month

The vaccine targets both the original strain of coronavirus and the Omicron variant.

Social media users shared a range of false claims this week

Health authorities say the vaccine is safe and effective in this age group

o serious safety concerns have been identified for this new bivalent treatment

Roughly 29 million people are eligible for an autumn booster but there are just 13 million doses of the new bivalent Moderna jab available